...
首页> 外文期刊>Coronary artery disease >Intracoronary administration of different doses of anisodamine in primary percutaneous coronary intervention: protective effect in patients with ST-segment elevation myocardial infarction
【24h】

Intracoronary administration of different doses of anisodamine in primary percutaneous coronary intervention: protective effect in patients with ST-segment elevation myocardial infarction

机译:不同剂量山administration碱在原发性经皮冠状动脉介入治疗中的冠状动脉内给药:对ST段抬高型心肌梗死患者的保护作用

获取原文
获取原文并翻译 | 示例
           

摘要

Objective The aim of this study was to evaluate the effects of intracoronary administration of anisodamine on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (STEMI) undergoing a primary percutaneous coronary intervention (pPCI).
机译:目的本研究旨在评估冠脉内给予山administration碱对初次经皮冠状动脉介入治疗(pPCI)的ST段抬高型心肌梗死(STEMI)患者心肌再灌注的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号